Introducing new vaccines in developing countries.
نویسندگان
چکیده
Vaccines offer the most cost-effective approach to controlling infectious diseases. Access to vaccines remains unequal and suboptimal, particularly in poorer developing countries. Introduction of new vaccines and long-term sustainability of immunization programs will require proactive planning from conception to implementation. International and national coordination efforts as well as local and cultural factors need to be known and accounted for. Adequate infrastructure should be in place for the monitoring of disease burden, vaccine effectiveness and vaccine safety, based on the common terminology and international consensus. This overview paper aims to raise awareness of the importance of introduction efforts for vaccines of special relevance to resource-poor countries. The target audiences are those involved in immunization programs, from planning or oversight roles to frontline providers, as well as health care professionals.
منابع مشابه
Translational research to assist policy decisions about introducing new vaccines in developing countries.
Few new-generation vaccines have found their way into public-health programmes for the poor in developing countries, and for those that have, delays of years or even decades after their licensure and introduction in industrialized countries have been the rule. Financial constraints and political obstacles have played major roles in delaying the introduction of the vaccines. Also contributing to...
متن کاملجنبههای اخلاقی تولید واکسنهای گیاهی
In recent years, vaccination programs have advanced significantly due to the progress in molecular biology and biotechnology. Research on plant-made vaccines has become a very tempting subject and transgenic plant technology to produce human or animal vaccines has attracted much attention. Numerous advantages have been reported for vaccine production in transgenic plants such as low cost, ease ...
متن کاملFinancial challenges in immunization and role of Health Technology Assessment as a Tool for Assessing New Vaccines in Developing Countries
Despite the advances in vaccine development, vaccine preventable diseases still add to the burden of childhood morbidity and mortality across the globe, particularly in developing countries. One of the major barriers preventing the access to sophisticated vaccines is the high vaccine price, the same factor that is preventing their implementation in developing countries with limited resources an...
متن کاملIntroducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease.
In the past 30 years, great strides have been made in immunizing infants and children routinely in developing countries under the Expanded Programme on Immunization. Despite this, the introduction of Haemophilus influenzae type b (Hib) vaccines has progressed rather slowly compared to previously-introduced vaccines for infant immunizations. This slower uptake has been attributed partly to the n...
متن کاملDevelopment of New Tuberculosis Vaccines: A Global Perspective on Regulatory Issues
In May 2005, the TB Vaccine Initiative of the World Health Organization (WHO) Initiative for Vaccine Research convened a working meeting of regulators, investigators, and clinicians from developing and developed countries involved in tuberculosis (TB) vaccine regulation and research (see Text S1 for a list of participants). The purpose of the meeting was to specifi cally discuss the regulatory ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Expert review of vaccines
دوره 12 12 شماره
صفحات -
تاریخ انتشار 2013